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  ABSTRACT 
 
Background: Inter-pregnancy interval (IPI), 
defined as the time interval between a live birth 
and estimated conception time of a subsequent 
pregnancy, has an established effect on peri-
natal outcome. The long-term impact of IPI on 
offspring is unknown. This study aimed to exa-
mine the effect of short and long IPIs on long-
term endo-metabolic health of offspring. 
Subjects and Method: This population-
based cohort study included singleton live 
births in parturient with at least one previous 
birth. Singleton deliveries between the years 
1991-2014 in a regional tertiary medical center 
were included. Offspring were followed until 18 
years of age for endo-metabolic related hospita-
lizations. Survival curves were used to compare 
cumulative incidence of endo-metabolic morbi-
dity, and Cox proportional hazards models to 
control for confounders. 
Results: During the study period 144,397 deli-
veries met the inclusion criteria. Offspring fol-
lowing long IPIs exhibited higher rates of endo-
metabolic related hospitalizations. Survival cur-
ve demonstrated a significantly higher cumu-
lative incidence of endo-metabolic morbidity in 
the long IPI group (p<0.001). The Cox model 
demonstrated long IPI to significantly increase 
the risk for endo-metabolic related hospitaliza-
tions during childhood (aHR= 1.34, 95%CI= 
1.06 to 1.70; p=0.015). 
Conclusion: Long IPI appears to have an in-
dependent impact on long-term endo-metabo-
lic health of the offspring. 
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BACKGROUND 
Interpregnancy interval (IPI) is the period 
between the birth of a live newborn and the 
conception of the next sibling (Class et al., 
2017). Various definitions have been used 
to define IPI. One commonly used defini-
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tion for “short IPI” refers to an interval of 
less than 18 months. Other researchers, 
however, have referred to a “short IPI” 
within a shorter range of less than three to 
six months (Li et al., 2018). There seems to 
be wide agreement regarding the definition 
of “long IPI,” which is frequently defined as 
an IPI longer than 59 or 60 months 
(Conde-Agudelo et al., 2006). 
The possible impact of IPI on peri-
natal outcomes has been investigated since 
the early 1920s (Li et al., 2018). A deviation 
from an average IPI length was shown to be 
associated with adverse outcomes in off-
spring. As IPI is a potentially modifiable 
risk factor, it attracted significant attention 
from the medical community (Li et al., 
2018).  
Both short and long IPIs have been 
reported to be associated with a signifi-
cantly increased risk of adverse perinatal 
outcomes, such as preterm delivery (PTD), 
low birth weight (LBW<2500 g), small for 
gestational age (SGA) and perinatal death 
(Conde-Agudelo et al., 2006). For instance, 
Ratzon et al. (2011) showed that short IPI 
increases the risk of adverse pregnancy out-
comes such as recurrent preterm delivery, 
and Class et al. (2017) found that long IPI 
increases the risk of PTD by 51%, the risk of 
LBW by 61%, and the incidence of SGA by 
54%.  
Studies suggest a difference in the 
direct influence of short or long IPIs. Short 
IPI associated adverse perinatal outcomes 
are largely attributed to familial confound-
ing. The association of long IPI with infant 
morbidities has more often been suggested 
to be independent of measured and un-
measured confounding factors (Class et al., 
2017). 
It seems that little is currently known 
about the influence of IPI on long-term 
childhood growth, development and health. 
This stands in contrast with the current 
growing interest and numerous publica-
tions on perinatal exposures and their 
impact on long term health of offspring 
(Barker et al., 2002; De Boo and Harding, 
2006).  
Some investigators explored the 
impact of several pregnancy and maternal 
characteristics on the endo-metabolic 
health of their offspring (Paz Levy et al., 
2017; Spiegel et al., 2019). Maternal charac-
teristics include adverse early pregnancy 
lipid profile and increased pre-pregnancy 
body mass index (BMI) (Oostvogels et al., 
2014; van Lieshout et al., 2017), as well as 
maternal diabetes or hypothyroidism (Abo-
kaf et al., 2018; Eshkoli et al., 2019). Some 
authors suggested these exposures to 
elevate the risk of later offspring metabolic 
health (van Lieshout et al., 2017). Child-
hood obesity has become a significant 
world-wide epidemic with important social 
and health burdens (Tran et al., 2019). In 
light of the disturbing increase over the last 
decade in the incidence of endo-metabolic 
disorders in children, the authors decided 
to examine this association. Their aim was 
to examine the effect of short (<6 months) 
and long (>60 months) IPIs on long-term 
endo-metabolic health of the offspring in a 
large population-based cohort study.  
 
SUBJECTS AND METHOD 
1. Study Design 
This population-based retrospective cohort 
study was conducted at the Soroka 
University Medical Center (SUMC), the sole 
tertiary medical center in the Negev 
(southern region of Israel). Thus, SUMC 
serves the entire population of the region, 
750,000 inhabitants in 2018 (Bureau and 
Statistics, 2019). Since SUMC is the major 
medical center in the south of Israel, most 
of the children born at SUMC are expected 
to be hospitalized there, if the need arises. 
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2. Population and Sample 
All singleton pregnancies of women who 
delivered at the SUMC and their infants (up 
to the age of 18 years) between January 
1991 and January 2014. Thus, the study is 
based on non-selective population data. 
The researchers excluded from the 
study women who delivered only once, 
multiple pregnancies, unknown gestational 
age, fetuses with major congenital malfo-
rmations or chromosomal abnormalities, 
and all perinatal mortality cases (intra-
uterine fetal death, intra-partum death and 
post-partum death). 
3. Operational Definition of Variables 
Short IPI was defined as less than 6 
months, intermediate IPI (between 6 to 60 
months), and long IPI was defined as an IPI 
of (more than 60 months).  
The variables obtained for the ana-
lysis included the following maternal fac-
tors: maternal age, parity, hypertensive dis-
orders in pregnancy, diabetes in pregnancy, 
and maternal obesity. Perinatal factors 
obtained included: gestational age and 
preterm delivery, and birthweight.  
The outcome variables included the fol-
lowing major pediatric metabolic diseases: 
diabetes mellitus, obesity, sex hormone 
disease, hypoglycemia and hyperlipidemia. 
All diagnoses are classified by the interna-
tional classification of disease (ICD-9, 
appendix A).  
4. Study Instruments 
In this population-based retrospective 
cohort study, data were collected from two 
computerized databases that were cross-
linked and merged. The first, was the peri-
natal database of the Obstetrics and Gyne-
cology department in SUMC, including 
information documented by obstetricians 
following each delivery. Experienced medi-
cal secretaries routinely review the infor-
mation before entering it into the database 
to ensure its maximal completeness and 
accuracy. Coding was performed after 
assessing medical prenatal care records as 
well as routine hospital documents.  
The second, was the SUMC general 
hospitalization records for children up to 
the age of 18 years, which includes demo-
graphic data and medical diagnoses ob-
tained upon admission and during hospi-
talization.  
5. Data Analysis 
Univariable analysis was performed to com-
pare background characteristics, and endo-
crine and metabolic morbidity, between the 
three study groups.  
The univariable analysis included 
Pearson Chi-square tests for categorical 
variables and ANOVA for continuous 
variables with normal distribution. The 
comparison was performed across all levels 
of exposure: short, intermediate and long 
IPI. Cumulative incidence rates of endocri-
ne and metabolic related hospitalizations of 
the offspring were compared using Kaplan-
Meier survival curve, using the log-rank test 
to determine significant differences. Two 
dummy variables were defined as short and 
long IPI groups. Those variables were 
created to compare the short and long IPI 
groups to the intermediate reference group. 
Cox proportional survival hazards 
model was conducted to compare endo-
metabolic associated hospitalizations risk 
among offspring born following a short or a 
long IPI. The model was adjusted for 
potential confounders based on the univari-
able analysis, and on clinical importance of 
the variables. The confounders included in 
the regression model were maternal factors 
(age, diabetes mellitus, obesity and hyper-
tensive disorders), as well as obstetrical 
factors (birthweight and gestational age 
upon delivery). All analyses were performed 
using SPSS (version 23) or STATA (version 
12) software. All analyses were 2-sided; and 
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a p value of less than 0.05 was considered 
significant.  
6. Research Ethics 
The institutional review board, in 
accordance with the Helsinki declaration, 
approved the study. 
 
RESULTS 
1. Sample Characteristics  
The inclusion criteria were met by 161,791 
deliveries during the study period. Of those 
22,851 (14.1%) occurred in women with 
short IPIs, 127,144 (78.6%) in women with 
intermediate IPIs, and 11,796 (7.3%) in 
women with long IPIs. Table 1a summarizes 
maternal characteristic for the different IPI 
categories. Mean maternal age upon 
delivery was different among the IPI 
groups. Mothers in the long IPI group were 
also more likely to be diagnosed with 
hypertensive disorders of pregnancy and 
diabetes (pre-gestational and gestational) 
with a high incidence of 10.2% in the long 
IPI group as compared to the intermediate 
(4.9%) and short (2.9%) IPI groups. 
Pregnancy outcomes are shown in Table 1b. 
Mean birthweight was smaller in the short 
IPI group and low Apgar score rates were 
higher in that group. The short and long IPI 
groups were both characterized by higher 
rates of preterm delivery and low birth-
weight, as compared with the intermediate 
IPI group. 
Table 1a. Maternal characteristics (continuous data) by interpregnancy interval 
(IPI) 
Characteristics 
Long IPI 
(>60 months) 
Intermediate IPI 
(6-60 months) 
Short IPI 
(<6 months) 
Mean  SD Mean SD Mean SD 
Maternal age (year)  34.50 4.28 29.2 5.33 26.14 5.07 
 
Table 1b. Maternal characteristics (categorical data) by interpregnancy interval 
(IPI) 
Characteristics 
Long IPI 
(>60 months) 
Intermediate IPI 
(6-60 months) 
Short IPI 
(<6 months) 
n % n % n % 
Parity        
2 to 4 9,241 78.3 80,938 63.7 15,829 69.3 
5+ 2,555 21.7 46,208 36.3 7,022 30.7 
Hypertensive disorder* 810 6.9 5,172 4.1 615 2.7 
Diabetes in Pregnancy** 1,202 10.2 6,251 4.9 673 2.9 
Obesity (BMI≥30 Kg/m2) 167 1.4 1340 1.1 189 0.8  
* Including pre-gestational, gestational hypertension, and preeclampsia. 
** Including pre-gestational and gestational diabetes mellitus.  
 
2. The result of bivariate analysis  
Long-term endocrine and metabolic hospi-
talization rates of offspring according to 
maternal IPI duration, are presented in 
Table 2a. During the 18-year follow-up 
period, 690 children were hospitalized with 
endocrine and metabolic morbidity. 
Children born following long IPIs exhibited 
higher rates of endo-metabolic related 
hospitalizations, as compared with the 
intermediate and short IPI groups (0.8% vs. 
0.5% vs. 0.4% respectively). Specifically, 
diabetes mellitus and obesity were more 
common in offspring born following long 
IPI.  
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Table 2a. Pregnancy outcomes (continous data) by interpregnancy interval (IPI) 
Outcomes 
Short IPI 
(<6 months) 
Intermediate IPI 
(6-60 months) 
Long IPI 
(>60 months) p 
Mean  SD Mean SD Mean SD 
Birth weight (gram) 3,171.2 487.4 3,258.1 497.5 3,235.6 516.2 <0.001 
Gestational age (weeks) 39.06 1.97 39.18 1.92 38.85 2.02 <0.001 
 
Table 2b. Pregnancy outcomes (categorical data) by interpregnancy interval (IPI) 
Characteristics 
Short IPI 
(<6 months) 
Intermediat
e IPI (6-60 
months) 
Long IPI 
(>60 months) p 
n % n % n % 
Gender        
Male   1,575 50.7  64,656 50.9  5,925 50.1 0.315 
Female   1,276 49.3  62,490 49.1  5,881 49.9  
Preterm delivery  1,799 7.9  7,498 5.9  909 7.7 <0.001 
Low birth weight (<2500 g)  1,569 6.9  6,637 5.2  782 6.6 <0.001 
Apgar score <7 at 1 min 1,272 5.6  6,374 5  550 4.7 <0.001 
Apgar score <7 at 5 min   786 3.4  3,088 2.4  162 1.4 <0.001 
 
Table 3. Selected long-term endocrine and metabolic morbidity of offspring born 
stratified by different interpregnancy interval (IPI) lengths. 
Offspring Long-Term 
Morbidity 
Short IPI  
(<6 months) 
Intermediate IPI 
(6-60 months) 
Long IPI 
(>60 months) p 
n % n % n % 
Thyroid disease  7 0.03 59 0.1 6 0.1  0.694 
Diabetes mellitus  10 0.1 110 0.1 16 0.1  0.048 
Hypoglycemia  23 0.1 138 0.1 21 0.3  0.195 
Hyperlipidemia  0 0 1 0.0008 0 0  0.875 
Obesity   30 0.2 180 0.2 38 0.3  <0.001 
Parathyroid disease   3 0.0001 21 0.0002 3 0.0003  0.805 
Adrenal disease  4 0.0002 20 0.02 4 0.0003  0.943 
Sex hormone disease  0 0 11 0.0001 4 0.0003  0.013 
Total endo-metabolic 
related hospitalization  
75 
0.4 528 
0.5  
87 
0.8  <0.001 
 
3. The result of multivariate analysis 
The Kaplan-Meier survival curve (Figure 1) 
demonstrated a significantly higher cumu-
lative incidence of long-term endocrine and 
metabolic morbidity in the long IPI group 
(log rank p<0.001). Table 4 presents the 
Cox proportional hazards model for the 
association between IPI and offspring long 
term endocrine and metabolic morbidity. 
The model controlled for maternal age, 
diabetes mellitus, hypertensive disorders, 
and obesity, as well as preterm delivery and 
birthweight. The model confirmed that 
infants born following long IPIs were at a 
significant and independent risk for long-
term endocrine and metabolic related hospi-
talizations during childhood (adjusted 
HR=1.34, 95%CI=1.06 to 1.70; p=0.015). 
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Figure 1. Kaplan-Meier survival curve for the cumulative incidence 
of endocrine and metabolic hospitalizations over time, from birth 
up to 18 years of age, according to inter pregnancy interval 
(log-rank p<0.001). 
 
Table 4. Multivariable analysis for the association between interpregnancy 
interval (IPI) and offspring long term endocrine and metabolic morbidity. 
Independent Variables 
adjusted Hazard 
Ratio 
95% CI 
p Lower 
limit 
Upper 
limit 
Intermediate IPI     
Long IPI (>60 months) 1.34 1.06 1.70 0.015 
Short IPI (<6 months) 1.01 0.79 1.31 0.88 
Maternal age (years) 0.96 0.94 0.97 <0.001 
Preterm delivery (<37 weeks) 1.28 0.96 1.72 0.1 
Birthweight (grams) 0.99 0.99 1.00 0.12 
Hypertensive disorders of pregnancy 1.21 0.89 1.66 0.23 
Diabetes mellitus (gestational and pre-
gestational) 
1.67 1.29 2.16 <0.001 
Obesity (BMI≥30 Kg/m2) 2.62 1.72 3.98 <0.001 
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DISCUSSION 
The researchers found that long IPI is 
strongly associated with an increased 
incidence of long-term endocrine and meta-
bolic morbidity of the offspring. Specifi-
cally, a significantly increased risk for dia-
betes mellitus and obesity in offspring born 
following long IPIs was demonstrated, as 
compared with the intermediate and short 
IPI groups. This original observation raises 
the question of whether long IPI represents 
an independent risk factor or whether this 
association can be explained by maternal 
and obstetrical confounding factors. Due to 
the large size of the cohort, the researchers 
were able to design a multiple logistic 
regression analysis controlling for many 
potential confounding factors. Factors 
controlled for in the model included 
maternal factors like age, diabetes mellitus, 
obesity and hypertensive disorders, and ob-
stetrical factors such as birthweight and 
preterm delivery. 
Current published literature focuses 
mainly on the significant effect of a short 
IPI and adverse perinatal outcome. For 
instance, short IPI had been associated with 
pre-term delivery, neonatal and fetal death, 
LBW, and SGA (Conde-Agudelo et al., 
2006; Mahande and Obure, 2016; Cecatti et 
al., 2008; Mignini et al., 2016). Long IPI, 
however, has been less investigated, yet 
some important associations have been 
suggested, including the risk for preterm 
delivery, LBW, SGA, fetal death, and 
increased odds of pre-eclampsia (Cecatti et 
al., 2008; Class et al., 2017; Mahande and 
Obure, 2016; Cecatti et al., 2008; Mignini 
et al., 2016; Kaul et al., 2019). As for the 
association between IPI and long-term 
health of the offspring, data is scarce. Li et 
al. (2018) suggested that long IPI is a risk 
factor for higher diastolic BP in offspring, 
which can potentially be explained by the 
confounding effect of advanced maternal 
age (Li et al., 2018). 
The prevailing view today is that 
endocrine and metabolic disease is not only 
determined by one’s genes, but also by the 
prenatal (i.e. intra-uterine) environment. 
This is in line with the currently widely 
accepted Barker hypothesis. Barker claimed 
that the fetus can be expected to make 
physiological adaptations in response to 
changes in its environment, in order to 
prepare itself for postnatal life (De Boo and 
Harding, 2006). For example, Barker’s 
‘thrifty phenotype’ hypothesis suggested 
that adult insulin resistance and type 2 dia-
betes could result from the persistence of a 
fetal glucose conserving adaptation in res-
ponse to intrauterine hypoglycemia (De 
Boo and Harding, 2006). This is consistent 
with a recent study suggesting an associa-
tion between in utero exposure to ges-
tational diabetes (GDM) and long-term in-
fant endocrine and metabolic morbidity, 
e.g. higher blood pressure and a predisposi-
tion for obesity, impaired glucose tolerance, 
diabetes, and metabolic syndrome (Abokaf 
et al., 2018). 
Long IPI is strongly linked with 
factors that could influence the prenatal 
environment. For instance, maternal age 
and weight, as well as nutritional status. 
The association between IPI and endo-
metabolic morbidity has not been previous-
ly studied. Therefore, the possibility that 
long IPI is independently linked with 
offspring endocrine and metabolic morbi-
dity during childhood is of significant 
public health interest, as birth spacing is re-
cognized as a modifiable risk factor (Regan 
et al., 2019).  
The major strength of the present 
study is the large sample upon which it is 
based. This allowed to control for several 
important confounding factors. Although 
the retrospective nature of this study is an 
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obvious limitation, the data was collected 
prospectively and recorded in real-time. 
Moreover, this study is based on non-selec-
tive population data. The authors used pre-
tested, standardized data collection forms, 
completed by trained data collectors, and a 
methodology based on a previous WHO 
global survey (Shah, 2008). Furthermore, 
since the medical center is the only one in 
the region, most children born in the 
hospital are likely to return to our center for 
medical treatment if warranted. The au-
thors therefore believe that as a regional 
hospital our study population included a 
relatively unbiased participation of mothers 
from all socioeconomic backgrounds.. It is 
also apparent that a randomized controlled 
study regarding the effects of IPI will not be 
possible, as mothers are not likely to agree 
to base their family planning decisions 
solely on a random study allocation.  
This study has several limitations. 
First, it is based on a large hospital-based 
database that does not include outpatient 
visits at non-hospital affiliated clinics. 
Therefore, cases of endocrine and meta-
bolic disease managed solely in an out-
patient setting were not accounted for. 
Furthermore, although the population is 
relatively non-mobile, it is clear that some 
patients may have moved to other regions 
and therefore missed, although these two 
limitations are true for all three study 
groups. 
Since this is a population-based ana-
lysis, this study can provide evidence only 
of an association rather than causation. Se-
veral potentially important factors were not 
available, such as childhood exposures, 
breast feeding, maternal weight or body 
mass index and socio-economic status. 
These factors have previously been shown 
to affect or protect the risk of endocrine and 
metabolic diseases (Boney et al., 2005; Kaul 
et al., 2019). For instance, lack of breast-
feeding in the first 5 months of life was 
associated with higher likelihood of being 
overweight in childhood (Boney et al., 
2005). 
In conclusion, our observation, that 
long IPI is significantly associated with an 
increase in long-term endocrine and meta-
bolic morbidity of the offspring, adds an 
important perspective to be considered 
during family planning. It seems that 
women can now be advised that prolonging 
the interval between births may increase 
endocrine and metabolic risk in their child. 
Further study is needed to assess whether 
this association can be attenuated 15 by 
interventions such as healthy lifestyle, 
weight maintenance, or physical activity. It 
remains to be seen whether counseling to 
optimize birth spacing can significantly 
reduce endocrine and metabolic mortality, 
and improve other immediate and long 
term pregnancy outcomes (Class et al., 
2017; Li et al., 2018; Conde-Agudelo et al., 
2006). 
Better understanding of this associa-
tion may therefore lead to practical public 
health recommendations and interventions, 
within the realm of family planning and 
disease prevention, in both the developed 
and developing world. 
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